Evidence map›Paper›PMID 41612445›Full record

ArticlePilot and feasibility studies2026

Stroke survivors' preferences for recovery-promoting drugs: development and piloting of a discrete choice experiment.

Nerida Firth, Alison Pearce, Oyelola Adegboye, Kathryn S Hayward, Julie Bernhardt, Robin Ray, Ruth N Barker

Abstract read
In one paragraph

Article in Pilot and feasibility studies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nerida FirthCollege of Medicine and Dentistry, James Cook University, Townsville, Australia. nerida.firth@my.jcu.edu.au.ORCID http://orcid.org/0000-0002-4390-8006
Alison PearceDaffodil Centre, the University of Sydney, a partnership with Cancer Council New South Wales, Sydney, Australia.ORCID http://orcid.org/0000-0002-5690-9542
Oyelola AdegboyeMenzies School of Health Research, Charles Darwin University, Darwin, Australia.ORCID http://orcid.org/0000-0002-9793-8024
Kathryn S HaywardDepartments of Physiotherapy and Medicine, University of Melbourne, Melbourne, Australia.ORCID http://orcid.org/0000-0001-5240-3264
Julie BernhardtStroke Theme, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia.ORCID http://orcid.org/0000-0002-2787-8484
Robin RayCollege of Medicine and Dentistry, James Cook University, Townsville, Australia.ORCID http://orcid.org/0000-0003-3947-0571
Ruth N BarkerThe Cairns Insititute, James Cook University, Cairns, Australia.ORCID http://orcid.org/0000-0002-2546-2581

Funding

National Health and Medical Research Council Investigator Fellowship 2016420Wellcome Trust 106607
6 · The paper itself

Abstract

backgroundRecovery-promoting drugs (RPDs) offer a pharmacological approach to improve motor recovery in stroke survivors. Investigating stroke survivors' preferences for taking RPDs would allow preferences to be considered during development of intervention protocols and optimise participant adherence. The aim of this study was to develop and pilot a robust discrete choice experiment (DCE) that examines stroke survivors' preferences for RPDs in combination with physical training to improve motor recovery. Pilot objectives were to assess the: (1) effectiveness of the data collection strategy; (2) effectiveness of the survey instrument design; and (3) robustness of the discrete choice experiment design.

methodsAn online DCE with two-alternative choice tasks consisting of six attributes (efficacy, out-of-pocket cost, side effects, treatment duration, dosage, and risk) depicting a stroke rehabilitation program involving RPDs. Respondents completed eleven choice tasks each: nine choice tasks divided into four blocks, plus a dominant choice and duplicate task. Participants were community-dwelling Australian stroke survivors. Outcomes included measures of data completeness, choice validity, and content validity. Conditional logit model analysis was used to estimate the marginal willingness-to-pay, and β coefficients for attributes and levels.

resultsSeventy-three stroke survivors completed the online DCE, with a survey completion rate of 89%. The survey instrument design was effective, with 94.5% and 84.9% respondents passing the dominant and duplicate choice tasks respectively. The DCE design was robust with clear and appropriate attributes and levels, accurate choice tasks and experimental design.

conclusionsSystematic development and piloting of this DCE has confirmed its robustness and feasibility. This study provides an example of robust procedures and reporting requirements for developing and piloting robust discrete choice experiments.

Indexed as

Discrete choice experimentDrugsMedicationPatient preferencesPilot studyStroke recoveryStroke rehabilitationTherapeutics

Identifiers

PMID41612445
PMCPMC12980900

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.